Items where Funder is Cancer Research UK Supplier No: 138573.
09/91/21
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
10-17751-99-01-G5
Long, E, Yin, J, Funderburk, KM et al. (20 more authors) (2022) Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity. American Journal of Human Genetics, 109 (12). pp. 2210-2229. ISSN 0002-9297
Yang, F, Mortlock, S, MacGregor, S et al. (5 more authors) (2021) Genetic Relationship Between Endometriosis and Melanoma. Frontiers in Reproductive Health, 3. 711123. ISSN 2673-3153
Haycock, PC, Borges, MC, Burrows, K et al. (32 more authors) (2023) The association between genetically elevated polyunsaturated fatty acids and risk of cancer. eBioMedicine, 91. 104510. ISSN 2352-3964
Potjer, TP, van der Grinten, TWJ, Lakeman, IMM et al. (8 more authors) (2021) Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma. Journal of Medical Genetics, 58 (11). pp. 760-766. ISSN 0022-2593
Liyanage, UE, Law, MH, Melanoma Meta-analysis Consortium et al. (3 more authors) (2020) Is there a causal relationship between vitamin D and melanoma risk? : A Mendelian randomization study. British Journal of Dermatology, 182 (1). pp. 97-103. ISSN 0007-0963
10039273
Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.
Hughes, L., Taylor, R.M. orcid.org/0000-0002-0853-0925, Beckett, A.E. orcid.org/0000-0001-5233-3390 et al. (7 more authors) (2024) The Emotional Impact of a Cancer Diagnosis: A Qualitative Study of Adolescent and Young Adult Experience. Cancers, 16 (7). 1332. ISSN 2072-6694
12/35/07
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
19002
Brownlie, RJ, Kennedy, R, Wilson, EB et al. (18 more authors) (2023) Cytokine receptor IL27RA is an NF-kB-responsive gene involved in CD38 upregulation in multiple myeloma. Blood Advances. ISSN 2473-9529
1T01-A321
Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
2012-005111-12
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
261747
Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.
Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
2R01EB018992-05
Martin, JW, Barducci, L, Scaglioni, B orcid.org/0000-0003-4891-8411 et al. (6 more authors) (2022) Robotic Autonomy for Magnetic Endoscope Biopsy. IEEE Transactions on Medical Robotics and Bionics, 4 (3). pp. 599-607. ISSN 2576-3202
Landewee, C.A. orcid.org/0000-0002-3177-1938, Winters, C., Martin, J. et al. (8 more authors) (2024) Magnetic flexible endoscope: a novel platform for diagnostic and therapeutic colonoscopy. iGIE, 3 (1). pp. 1-4. ISSN 2949-7086
4616
Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
6R01EB018992
Landewee, C.A. orcid.org/0000-0002-3177-1938, Winters, C., Martin, J. et al. (8 more authors) (2024) Magnetic flexible endoscope: a novel platform for diagnostic and therapeutic colonoscopy. iGIE, 3 (1). pp. 1-4. ISSN 2949-7086
818045
Martin, JW, Barducci, L, Scaglioni, B orcid.org/0000-0003-4891-8411 et al. (6 more authors) (2022) Robotic Autonomy for Magnetic Endoscope Biopsy. IEEE Transactions on Medical Robotics and Bionics, 4 (3). pp. 599-607. ISSN 2576-3202
952118
Martin, JW, Barducci, L, Scaglioni, B orcid.org/0000-0003-4891-8411 et al. (6 more authors) (2022) Robotic Autonomy for Magnetic Endoscope Biopsy. IEEE Transactions on Medical Robotics and Bionics, 4 (3). pp. 599-607. ISSN 2576-3202
9R01/0004
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
A14923
Baxter, M.A. orcid.org/0000-0002-5773-8650, Spender, L.C., Walsh, S. et al. (6 more authors) (2023) Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial. Cancers, 15 (9). 2591. ISSN 2072-6694
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
A19121
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
A23814
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
A24078
Royle, K-L orcid.org/0000-0003-0225-1199, Coulson, AB, Ramasamy, K et al. (26 more authors) (2022) Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ Open, 12 (11). e063037. ISSN 2044-6055
A24939
Baxter, M.A. orcid.org/0000-0002-5773-8650, Spender, L.C., Walsh, S. et al. (6 more authors) (2023) Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial. Cancers, 15 (9). 2591. ISSN 2072-6694
A25447
McNamara, MG, Swain, J, Craig, Z et al. (21 more authors) (2023) NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma. eClinicalMedicine, 60. 102015. ISSN 2589-5370
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
Agbuduwe, C, Iqbal, G, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2022) Clinical Characteristics and Outcomes of IgD Myeloma: Experience across UK National Trials. Blood Advances, 6 (17). pp. 5113-5123. ISSN 2473-9529
Hillmen, P, Pitchford, A, Bloor, A et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045
Hillmen, P., Pitchford, A., Bloor, A. et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045
Platt, JR, Williams, CJM orcid.org/0000-0002-1574-653X, Craig, Z et al. (4 more authors) (2023) Personalising Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer: Protocols for the International Phase III FOxTROT2 and FOxTROT3 Randomised-Controlled Trials. Colorectal Disease. ISSN 1462-8910
Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793
Snowden, JA, Ahmedzai, SH, Cox, A et al. (10 more authors) (2022) Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study. Bone Marrow Transplantation, 57 (10). pp. 1507-1513. ISSN 0268-3369
Royle, K-L orcid.org/0000-0003-0225-1199, Coulson, AB, Ramasamy, K et al. (26 more authors) (2022) Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ Open, 12 (11). e063037. ISSN 2044-6055
Williams, C, Emmerson, J, Beggs, AD et al. (12 more authors) (2022) A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442). In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 03-07 Jun 2022, Online & Chicago, IL, USA. American Society of Clinical Oncology .
A28301
Gilbert, A orcid.org/0000-0002-9142-1227, Homer, V, Brock, K et al. (18 more authors) (2022) Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision. The Lancet Healthy Longevity, 3 (12). e825-e838. ISSN 2666-7568
A28832
Andratschke, N., Willmann, J., Appelt, A.L. orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radio-therapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045
Andratschke, N, Willmann, J, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045
Fatania, K orcid.org/0000-0003-2421-1083, Mohamud, F, Clark, A et al. (5 more authors) (2022) Intensity standardization of MRI prior to radiomic feature extraction for artificial intelligence research in glioma-a systematic review. European Radiology, 32 (10). pp. 7014-7025. ISSN 0938-7994
Murray, LJ orcid.org/0000-0003-0658-6455, Appelt, AL, Ajithkumar, T et al. (9 more authors) (2023) Re-irradiation: From Cell Lines to Patients, Filling the (Science) Gap in the Market. Clinical Oncology, 35 (5). pp. 318-322. ISSN 0936-6555
Arp, D.T. orcid.org/0009-0007-7980-5539, Appelt, A.L. orcid.org/0000-0003-2792-9218, Jensen, L.H. et al. (6 more authors) (2024) Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study. Physica Medica, 118. 103206. ISSN 1120-1797
Underwood, TSA, McNamara, AL, Appelt, A orcid.org/0000-0003-2792-9218 et al. (3 more authors) (2022) A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE). Radiotherapy and Oncology, 175. pp. 79-92. ISSN 0167-8140
Theophanous, S orcid.org/0000-0002-4148-3905, Lønne, P-I, Choudhury, A et al. (25 more authors) (2022) Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study. Diagnostic and Prognostic Research, 6 (1). 14. p. 14. ISSN 2397-7523
A29067
Lincoln, A, Benton, S, Piggott, C et al. (6 more authors) (2022) Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study. BMC Cancer, 22 (1). 1144. ISSN 1471-2407
Bose, M, Wood, HM orcid.org/0000-0003-3009-5904, Young, C orcid.org/0000-0001-5709-4413 et al. (3 more authors) (2023) Analysis of an Indian colorectal cancer faecal microbiome collection demonstrates universal colorectal cancer-associated patterns, but closest correlation with other Indian cohorts. BMC Microbiology, 23. 52. ISSN 1471-2180
A29212
Brownlie, RJ, Kennedy, R, Wilson, EB et al. (18 more authors) (2023) Cytokine receptor IL27RA is an NF-kB-responsive gene involved in CD38 upregulation in multiple myeloma. Blood Advances. ISSN 2473-9529
C18803/A7264
Snowden, JA, Ahmedzai, SH, Cox, A et al. (10 more authors) (2022) Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study. Bone Marrow Transplantation, 57 (10). pp. 1507-1513. ISSN 0268-3369
C23434/A23706
Birch, RJ orcid.org/0000-0003-1579-1397, Downing, A orcid.org/0000-0002-0335-7801, Finan, PJ et al. (3 more authors) (2021) Improving outcome prediction in individuals with colorectal cancer and diabetes by accurate assessment of vascular complications: Implications for clinical practice. European Journal of Surgical Oncology, 47 (5). pp. 999-1004. ISSN 0748-7983
Birch, RJ orcid.org/0000-0003-1579-1397, Peckham, D orcid.org/0000-0001-7723-1868, Wood, HM orcid.org/0000-0003-3009-5904 et al. (7 more authors) (2022) The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study. Journal of Cystic Fibrosis. ISSN 1569-1993
Taylor, JC orcid.org/0000-0002-2518-5799, Iversen, LH, Burke, D orcid.org/0000-0002-4342-7464 et al. (5 more authors) (2022) Differences in the management of patients requiring an emergency resection for colonic cancer in two European populations. BJS Open, 6 (5). zrac126. ISSN 2474-9842
C55663/A23269
Salmond, R orcid.org/0000-0002-1807-1056 (2023) Regulation of T cell activation and metabolism by Transforming Growth Factor-Beta. Biology, 12 (2). 297. ISSN 2079-7737
C6003/A10079
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
C6003/A15546
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
C6003/A3830
Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
C6003/A6407
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
C6003/A7367
Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
Williams, C, Emmerson, J, Beggs, AD et al. (12 more authors) (2022) A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442). In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 03-07 Jun 2022, Online & Chicago, IL, USA. American Society of Clinical Oncology .
C6003/A7686
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
C64904/A27744
Winters, C., Norton, J., Valdastri, P. orcid.org/0000-0002-2280-5438 et al. (1 more author) (2023) P233 Barriers and facilitators to colonoscopy in patients and endoscopists. In: BSG LIVE’23, 19-22 Jun 2023, Liverpool.
Winters, C., Norton, J., Valdastri, P. orcid.org/0000-0002-2280-5438 et al. (1 more author) (2023) P234 Patient and endoscopist perceptions of new technologies in colonoscopy. In: BSG LIVE’23, 19-22 Jun 2023, Liverpool.
Winters, C orcid.org/0000-0001-5773-2876, Subramanian, V orcid.org/0000-0003-3603-0861 and Valdastri, P orcid.org/0000-0002-2280-5438 (2022) Robotic, self-propelled, self-steerable, and disposable colonoscopes: Reality or pipe dream? A state of the art review. World Journal of Gastroenterology, 28 (35). pp. 5093-5110. ISSN 1007-9327
Martin, JW, Barducci, L, Scaglioni, B orcid.org/0000-0003-4891-8411 et al. (6 more authors) (2022) Robotic Autonomy for Magnetic Endoscope Biopsy. IEEE Transactions on Medical Robotics and Bionics, 4 (3). pp. 599-607. ISSN 2576-3202
Landewee, C.A. orcid.org/0000-0002-3177-1938, Winters, C., Martin, J. et al. (8 more authors) (2024) Magnetic flexible endoscope: a novel platform for diagnostic and therapeutic colonoscopy. iGIE, 3 (1). pp. 1-4. ISSN 2949-7086
C7775/A7424
Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.
Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.
Hughes, L., Taylor, R.M. orcid.org/0000-0002-0853-0925, Beckett, A.E. orcid.org/0000-0001-5233-3390 et al. (7 more authors) (2024) The Emotional Impact of a Cancer Diagnosis: A Qualitative Study of Adolescent and Young Adult Experience. Cancers, 16 (7). 1332. ISSN 2072-6694
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
C7852/A19772
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
Shiu, K-K, Seligmann, JF orcid.org/0000-0003-4379-6005, Graham, J et al. (15 more authors) (2022) NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumor mutation burden for high-risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer. In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting I, 03-07 Jun 2022, Chicago, USA. American Society of Clinical Oncology .
Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
Williams, C, Emmerson, J, Beggs, AD et al. (12 more authors) (2022) A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442). In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 03-07 Jun 2022, Online & Chicago, IL, USA. American Society of Clinical Oncology .
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
CRUK 05 06 BUDGET
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
CTUQQR-Dec22/100002
Royle, K.-L. orcid.org/0000-0003-0225-1199, Meads, D., Visser-Rogers, J.K. et al. (2 more authors) (2023) How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review. Trials, 24. 708. ISSN 1745-6215
Rawstron, A., Webster, N., Dalal, S. et al. (15 more authors) (2023) Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. In: Blood. 65th ASH: Annual Meeting & Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , p. 632.
Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793
DRIKXHAAS
Slevin, F orcid.org/0000-0002-7176-904X, Beasley, M, Speight, R et al. (5 more authors) (2021) Evaluation of Clinician Contouring for Pancreatic Stereotactic Ablative Radiotherapy During a Contouring Workshop Organised by the Royal College of Radiologists. Clinical Oncology, 33 (3). e196-e197. ISSN 0936-6555
Slevin, F orcid.org/0000-0002-7176-904X and Henry, AM orcid.org/0000-0002-5379-6618 (2021) Muscle-invasive Bladder Cancer in the Elderly Patient With a Focus on Hypofractionated Radiotherapy. Clinical Oncology, 33 (6). pp. 369-375. ISSN 0936-6555
Brown, S, Beasley, M, Mcnair, H et al. (3 more authors) (2019) A survey of the practice of stereotactic ablative radiotherapy for lung cancer in the UK on behalf of the Advanced Radiotherapy Technologies Network (ART-NET). In: 17th Annual British Thoracic Oncology Group Conference 2019, 23-25 Jan 2019, Dublin, Ireland.
EDDPMA-May21\100024
Smith, L orcid.org/0000-0002-4280-6323, Carmichael, J, Cook, G orcid.org/0000-0001-7196-7364 et al. (2 more authors) (2023) Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study. Cancers, 15 (3). 975. ISSN 2072-6694
EMSG1J3R
Lloyd, KE orcid.org/0000-0002-0420-2342, Hall, LH, King, N orcid.org/0000-0002-4215-2323 et al. (6 more authors) (2022) Aspirin use for cancer prevention: a systematic review of public, patient and healthcare provider attitudes and adherence behaviours. Preventive Medicine, 154. 106872. ISSN 0091-7435
Lloyd, KE orcid.org/0000-0002-0420-2342, Hall, LH, Ziegler, L et al. (5 more authors) (2022) A factorial randomised trial investigating factors influencing general practitioners’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a registered report. British Journal of General Practice. BJGP.2021.0610. ISSN 0960-1643
EP/V047914/1
Martin, JW, Barducci, L, Scaglioni, B orcid.org/0000-0003-4891-8411 et al. (6 more authors) (2022) Robotic Autonomy for Magnetic Endoscope Biopsy. IEEE Transactions on Medical Robotics and Bionics, 4 (3). pp. 599-607. ISSN 2576-3202
ES/S00565X/1
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
Fund No IT01
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
GCRFNG\100433
Bose, M, Wood, HM orcid.org/0000-0003-3009-5904, Young, C orcid.org/0000-0001-5709-4413 et al. (3 more authors) (2023) Analysis of an Indian colorectal cancer faecal microbiome collection demonstrates universal colorectal cancer-associated patterns, but closest correlation with other Indian cohorts. BMC Microbiology, 23. 52. ISSN 1471-2180
L386
Gilbert, A orcid.org/0000-0002-9142-1227, Homer, V, Brock, K et al. (18 more authors) (2022) Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision. The Lancet Healthy Longevity, 3 (12). e825-e838. ISSN 2666-7568
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
L386-RA/2015/R2/003
Seligmann, J., Morton, D., Seymour, M. et al. (11 more authors) (2023) 552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel. In: Annals of Oncology. ESMO Congress 2023, 2023-10-20 2023-10-24, Madrid, Spain. Elsevier , S412-S412.
L387
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
L394
Taylor, JC orcid.org/0000-0002-2518-5799, Iversen, LH, Burke, D orcid.org/0000-0002-4342-7464 et al. (5 more authors) (2022) Differences in the management of patients requiring an emergency resection for colonic cancer in two European populations. BJS Open, 6 (5). zrac126. ISSN 2474-9842
L394-RA/2015/R1/003
Platt, J.R., Williams, C. orcid.org/0000-0002-1574-653X, West, N. orcid.org/0000-0002-0346-6709 et al. (2 more authors) (2023) Exploring the radiological differences of lymph nodes between mismatch repair deficient and mismatch repair proficient colon cancer. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .
L430
Williams, C. orcid.org/0000-0002-1574-653X, White, M., Platt, J.R. et al. (14 more authors) (2023) The FOxTROT platform: Clinical trials and exploratory research for personalization of neoadjuvant (NA) therapy in locally advanced colon cancer (LACC)—ISRCTN83842641. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
MR/M016587/1
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
MR/M019012/1
Davies, J, Muralidhar, S, Randerson-Moor, J et al. (15 more authors) (2022) Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicity. Pigment Cell and Melanoma Research, 35 (2). pp. 252-267. ISSN 1755-1471
NAF\R2\180782
Castaneda-Garcia, C, Iyer, V, Nsengimana, J et al. (11 more authors) (2022) Defining novel causal SNPs and linked phenotypes at melanoma-associated loci. Human Molecular Genetics, 31 (17). pp. 2845-2856. ISSN 0964-6906
NF-SI-0514-10070
Gilbert, A orcid.org/0000-0002-9142-1227, Homer, V, Brock, K et al. (18 more authors) (2022) Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision. The Lancet Healthy Longevity, 3 (12). e825-e838. ISSN 2666-7568
Taylor, JC orcid.org/0000-0002-2518-5799, Iversen, LH, Burke, D orcid.org/0000-0002-4342-7464 et al. (5 more authors) (2022) Differences in the management of patients requiring an emergency resection for colonic cancer in two European populations. BJS Open, 6 (5). zrac126. ISSN 2474-9842
NIHR 129268
Williams, C, Emmerson, J, Beggs, AD et al. (12 more authors) (2022) A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442). In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 03-07 Jun 2022, Online & Chicago, IL, USA. American Society of Clinical Oncology .
NIHR200162
Bose, M, Wood, HM orcid.org/0000-0003-3009-5904, Young, C orcid.org/0000-0001-5709-4413 et al. (3 more authors) (2023) Analysis of an Indian colorectal cancer faecal microbiome collection demonstrates universal colorectal cancer-associated patterns, but closest correlation with other Indian cohorts. BMC Microbiology, 23. 52. ISSN 1471-2180
NIHR300693
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
NO EXT REF GIVEN
Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
NOT GIVEN
Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
No Ext Ref
Royle, K-L orcid.org/0000-0003-0225-1199, Coulson, AB, Ramasamy, K et al. (26 more authors) (2022) Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ Open, 12 (11). e063037. ISSN 2044-6055
No Ext Ref Given
Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
No ref given
McNamara, MG, Swain, J, Craig, Z et al. (21 more authors) (2023) NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma. eClinicalMedicine, 60. 102015. ISSN 2589-5370
Not Known
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
Gil, N, Fisher, A, Beeken, RJ orcid.org/0000-0001-8287-9351 et al. (5 more authors) (2022) The role of partner support for health behaviours in people living with and beyond cancer: A qualitative study. Psycho-oncology, 31 (11). pp. 1997-2006. ISSN 1057-9249
Baxter, M.A. orcid.org/0000-0002-5773-8650, Spender, L.C., Walsh, S. et al. (6 more authors) (2023) Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial. Cancers, 15 (9). 2591. ISSN 2072-6694
Arp, D.T. orcid.org/0009-0007-7980-5539, Appelt, A.L. orcid.org/0000-0003-2792-9218, Jensen, L.H. et al. (6 more authors) (2024) Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study. Physica Medica, 118. 103206. ISSN 1120-1797
Underwood, TSA, McNamara, AL, Appelt, A orcid.org/0000-0003-2792-9218 et al. (3 more authors) (2022) A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE). Radiotherapy and Oncology, 175. pp. 79-92. ISSN 0167-8140
Lally, P, Miller, NE, Lawrence, C et al. (2 more authors) (2023) Associations of self-reported and device-assessed physical activity with fatigue, quality of life, and sleep quality in adults living with and beyond cancer. Journal of Sport and Health Science, 12 (6). pp. 664-673. ISSN 2095-2546
Yang, F, Mortlock, S, MacGregor, S et al. (5 more authors) (2021) Genetic Relationship Between Endometriosis and Melanoma. Frontiers in Reproductive Health, 3. 711123. ISSN 2673-3153
Haycock, PC, Borges, MC, Burrows, K et al. (32 more authors) (2023) The association between genetically elevated polyunsaturated fatty acids and risk of cancer. eBioMedicine, 91. 104510. ISSN 2352-3964
Haycock, PC, Borges, MC, Burrows, K et al. (32 more authors) (2023) The association between genetically elevated polyunsaturated fatty acids and risk of cancer. eBioMedicine, 91. 104510. ISSN 2352-3964
Potjer, TP, van der Grinten, TWJ, Lakeman, IMM et al. (8 more authors) (2021) Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma. Journal of Medical Genetics, 58 (11). pp. 760-766. ISSN 0022-2593
Liyanage, UE, Law, MH, Melanoma Meta-analysis Consortium et al. (3 more authors) (2020) Is there a causal relationship between vitamin D and melanoma risk? : A Mendelian randomization study. British Journal of Dermatology, 182 (1). pp. 97-103. ISSN 0007-0963
Theophanous, S orcid.org/0000-0002-4148-3905, Lønne, P-I, Choudhury, A et al. (25 more authors) (2022) Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study. Diagnostic and Prognostic Research, 6 (1). 14. p. 14. ISSN 2397-7523
Land, J, McCourt, O, Heinrich, M et al. (6 more authors) (2020) The adapted Zelen was a feasible design to trial exercise in myeloma survivors. Journal of Clinical Epidemiology, 125. pp. 76-83. ISSN 0895-4356
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
PRISM
Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407
R2683CNR
Corry, SM, McCorry, AMB, Lannagan, TRM et al. (31 more authors) (2022) Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. Gut, 71 (12). pp. 2502-2517. ISSN 0017-5749
Malla, S.B. orcid.org/0000-0001-5862-3815, Byrne, R.M. orcid.org/0000-0001-6505-6345, Lafarge, M.W. et al. (40 more authors) (2024) Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer. Nature Genetics. ISSN 1061-4036
RCCCTF-Nov21\100001
Baxter, M.A. orcid.org/0000-0002-5773-8650, Spender, L.C., Walsh, S. et al. (6 more authors) (2023) Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial. Cancers, 15 (9). 2591. ISSN 2072-6694
Williams, C, Emmerson, J, Beggs, AD et al. (12 more authors) (2022) A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442). In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 03-07 Jun 2022, Online & Chicago, IL, USA. American Society of Clinical Oncology .
Seligmann, J., Morton, D., Seymour, M. et al. (11 more authors) (2023) 552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel. In: Annals of Oncology. ESMO Congress 2023, 2023-10-20 2023-10-24, Madrid, Spain. Elsevier , S412-S412.
Platt, J.R., Williams, C. orcid.org/0000-0002-1574-653X, West, N. orcid.org/0000-0002-0346-6709 et al. (2 more authors) (2023) Exploring the radiological differences of lymph nodes between mismatch repair deficient and mismatch repair proficient colon cancer. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .
Williams, C. orcid.org/0000-0002-1574-653X, White, M., Platt, J.R. et al. (14 more authors) (2023) The FOxTROT platform: Clinical trials and exploratory research for personalization of neoadjuvant (NA) therapy in locally advanced colon cancer (LACC)—ISRCTN83842641. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
RCS REF 08-0843 SUBCONTR
Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.
Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
RV-CL-MM-PI-13264
Royle, K-L orcid.org/0000-0003-0225-1199, Coulson, AB, Ramasamy, K et al. (26 more authors) (2022) Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ Open, 12 (11). e063037. ISSN 2044-6055
SRC012
Birch, RJ orcid.org/0000-0003-1579-1397, Peckham, D orcid.org/0000-0001-7723-1868, Wood, HM orcid.org/0000-0003-3009-5904 et al. (7 more authors) (2022) The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study. Journal of Cystic Fibrosis. ISSN 1569-1993
TS/S012702/1 104687
Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.
TYA CAN COHORT STY G569
Hughes, L., Taylor, R.M. orcid.org/0000-0002-0853-0925, Beckett, A.E. orcid.org/0000-0001-5233-3390 et al. (7 more authors) (2024) The Emotional Impact of a Cancer Diagnosis: A Qualitative Study of Adolescent and Young Adult Experience. Cancers, 16 (7). 1332. ISSN 2072-6694
Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249
UCL Ref - CID306331
Kennedy, F orcid.org/0000-0002-4910-2505, Lally, P, Miller, NE et al. (5 more authors) (2023) Fatigue, quality of life and associations with adherence to the World Cancer Research Fund guidelines for health behaviours in 5835 adults living with and beyond breast, prostate and colorectal cancer in England: A cross-sectional study. Cancer Medicine, 12 (11). pp. 12705-12716. ISSN 2045-7634
Smith, S., Fisher, A., Lally, P. J. et al. (4 more authors) (2024) Perceiving a Need for Dietary Change in Adults Living With and Beyond Cancer: A Cross Sectional Study. Cancer Medicine, 13 (4). e7073. ISSN 2045-7634
Smith, S., Lally, P., Steptoe, A. et al. (3 more authors) (2024) Prevalence of loneliness and associations with health behaviours and body mass index in 5835 people living with and beyond cancer: a cross-sectional study. BMC Public Health, 24 (1). 635.
Lally, P, Miller, NE, Lawrence, C et al. (2 more authors) (2023) Associations of self-reported and device-assessed physical activity with fatigue, quality of life, and sleep quality in adults living with and beyond cancer. Journal of Sport and Health Science, 12 (6). pp. 664-673. ISSN 2095-2546
Land, J, McCourt, O, Heinrich, M et al. (6 more authors) (2020) The adapted Zelen was a feasible design to trial exercise in myeloma survivors. Journal of Clinical Epidemiology, 125. pp. 76-83. ISSN 0895-4356
X120
Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029
c588/A19167
Castaneda-Garcia, C, Iyer, V, Nsengimana, J et al. (11 more authors) (2022) Defining novel causal SNPs and linked phenotypes at melanoma-associated loci. Human Molecular Genetics, 31 (17). pp. 2845-2856. ISSN 0964-6906
Birkeälv, S, Harland, M, Matsuyama, LSAS et al. (15 more authors) (2023) Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma. Journal of Pathology, 259 (1). pp. 56-68. ISSN 0022-3417
Davies, J, Muralidhar, S, Randerson-Moor, J et al. (15 more authors) (2022) Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicity. Pigment Cell and Melanoma Research, 35 (2). pp. 252-267. ISSN 1755-1471
Long, E, Yin, J, Funderburk, KM et al. (20 more authors) (2022) Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity. American Journal of Human Genetics, 109 (12). pp. 2210-2229. ISSN 0002-9297
Yang, F, Mortlock, S, MacGregor, S et al. (5 more authors) (2021) Genetic Relationship Between Endometriosis and Melanoma. Frontiers in Reproductive Health, 3. 711123. ISSN 2673-3153
Haycock, PC, Borges, MC, Burrows, K et al. (32 more authors) (2023) The association between genetically elevated polyunsaturated fatty acids and risk of cancer. eBioMedicine, 91. 104510. ISSN 2352-3964
Potjer, TP, van der Grinten, TWJ, Lakeman, IMM et al. (8 more authors) (2021) Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma. Journal of Medical Genetics, 58 (11). pp. 760-766. ISSN 0022-2593
Liyanage, UE, Law, MH, Melanoma Meta-analysis Consortium et al. (3 more authors) (2020) Is there a causal relationship between vitamin D and melanoma risk? : A Mendelian randomization study. British Journal of Dermatology, 182 (1). pp. 97-103. ISSN 0007-0963